home / stock / phge / phge quote
Last: | $0.2251 |
---|---|
Change Percent: | -8.44% |
Open: | $0.3199 |
Close: | $0.2251 |
High: | $0.3199 |
Low: | $0.223 |
Volume: | 919,008 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.2251 | $0.3199 | $0.2251 | $0.3199 | $0.223 | 919,008 | 07-22-2024 |
$0.295 | $0.3219 | $0.295 | $0.348 | $0.2804 | 192,592 | 07-19-2024 |
$0.32 | $0.34 | $0.32 | $0.34 | $0.311 | 69,316 | 07-18-2024 |
$0.34 | $0.3473 | $0.34 | $0.358 | $0.3306 | 134,481 | 07-17-2024 |
$0.358 | $0.35 | $0.358 | $0.358 | $0.31 | 292,139 | 07-16-2024 |
$0.34 | $0.35 | $0.34 | $0.3592 | $0.325 | 108,922 | 07-15-2024 |
$0.34 | $0.3379 | $0.34 | $0.3442 | $0.33 | 88,254 | 07-12-2024 |
$0.333 | $0.355 | $0.333 | $0.355 | $0.3309 | 290,938 | 07-11-2024 |
$0.363 | $0.3355 | $0.363 | $0.3864 | $0.33 | 301,121 | 07-10-2024 |
$0.3355 | $0.3233 | $0.3355 | $0.34 | $0.3233 | 48,544 | 07-09-2024 |
$0.3301 | $0.346 | $0.3301 | $0.35 | $0.323 | 54,919 | 07-08-2024 |
$0.3465 | $0.3335 | $0.3465 | $0.3545 | $0.33 | 37,938 | 07-05-2024 |
$0.3425 | $0.363 | $0.3425 | $0.37 | $0.3337 | 50,364 | 07-04-2024 |
$0.3425 | $0.363 | $0.3425 | $0.37 | $0.33371 | 50,364 | 07-03-2024 |
$0.3516 | $0.3586 | $0.3516 | $0.381 | $0.35 | 92,065 | 07-02-2024 |
$0.3412 | $0.35 | $0.3412 | $0.35 | $0.3328 | 25,864 | 07-01-2024 |
$0.3361 | $0.3299 | $0.3361 | $0.35 | $0.3299 | 56,766 | 06-28-2024 |
$0.3382 | $0.3424 | $0.3382 | $0.345 | $0.335 | 26,670 | 06-27-2024 |
$0.34 | $0.35 | $0.34 | $0.35 | $0.311 | 46,690 | 06-26-2024 |
$0.3319 | $0.337 | $0.3319 | $0.3497 | $0.315 | 90,649 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Chardan Healthcare Acquisition Corp. Company Name:
PHGE Stock Symbol:
NYSE Market:
Chardan Healthcare Acquisition Corp. Website:
GAITHERSBURG, Md., July 10, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company&...
GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today annou...
GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today annou...